BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

ABEO

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

  • Abeona Therapeutics congratulated Ultragenyx on FDA approval of FAYUVI gene therapy for Sanfilippo syndrome type ASep 18, 2026
  • Cincinnati Children's becomes the seventh qualified treatment center for ZEVASKYN®Jul 21, 2026
  • Abeona Therapeutics activates Children's Hospital of Philadelphia as a treatment center for ZEVASKYNMay 11, 2026
  • Abeona announced a new qualified treatment center for ZEVASKYN in New YorkApr 2, 2026
  • Abeona Therapeutics announces new qualified treatment center for ZEVASKYN® in TexasDec 11, 2025

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy